Effects of 5-aminolevulinic acid on the quality of life in patients with glioblastoma
Phase 2
Recruiting
- Conditions
- Glioblastoma multiforme.Malignant neoplasm of brain, unspecifiedC71.9
- Registration Number
- IRCT20140810018745N12
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Patients with written informed consent; randomized; patients with glioblastoma multiforme; patients with KPS above 70 or ECOG 0-1; patients with 30-70 years
Exclusion Criteria
Patients with renal, cardiac, and hepatic problems; Patients with intestinal obstruction; Patients with GFR less than 30; Patients with immunodeficiency such as AIDS and hepatitis; Patients with low white blood cell (less of 1000).
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of life. Timepoint: At the beginning and end of the study. Method of measurement: The questionaries’.
- Secondary Outcome Measures
Name Time Method